Business ❯Pharmaceutical Industry

Drug Companies

Market Impact Eli Lilly Regulations Pricing Strategies Lawsuits Bristol Myers Squibb CEOs GSK Investor Relations

Congress Stalls on PBM Reforms as Trump Vows to Eliminate 'Middlemen'

Proposed legislation to regulate pharmacy benefit managers is delayed, raising questions about future drug pricing reform efforts.

Ozempic Likely Target for 2027 Medicare Price Negotiations

Jury Finds Zantac Not Responsible for Illinois Woman's Colon Cancer

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal